HM Pharmaceuticals SRL
HM Pharmaceuticals reported total assets of 57,918 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of HM Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HM Pharmaceuticals's annual accounts
| 2025 | |
|---|---|
| Net result | 36,473 € |
| Equity | 38,973 € |
| Cash | 33,737 € |
| EBITDA | 47,053 € |
| Total assets | 57,918 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
HM Pharmaceuticals's financial analysis
- Solvency67.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HM Pharmaceuticals
HM Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.811.930
- VAT number
- BE1013811930
- Peppol
- Registered · 0208:1013811930 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Sep 2024
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
HM Pharmaceuticals (SRL) has been based in Uccle since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,473 € and equity of 38,973 €; its revenue is not published. Its solvency stands at 67.3%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to HM Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Aamal Europe Investment Retail sale of cosmetic and toilet articles Machelen (Brab.) · balance sheet 211,946 €
- Pharmacie Arnaud Nicolas Retail sale of pharmaceutical products Ixelles · balance sheet 161,036 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Bourda Retail sale of pharmaceutical products Ghent · balance sheet 51,304 €
- Danneels Elien Retail sale of pharmaceutical products Koksijde · balance sheet 73,229 €
- Mathilde Kesteman Retail sale of pharmaceutical products Esneux · balance sheet 40,429 €
- MKR Consulting Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 40,911 €
- Labotique Retail sale of cosmetic and toilet articles Sint-Truiden · balance sheet 78,403 €
Frequently asked questions about HM Pharmaceuticals
What is the revenue of HM Pharmaceuticals?
HM Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HM Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE1013811930 for HM Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 1013.811.930.
Where is the registered office of HM Pharmaceuticals?
According to the CBE register, the registered office of HM Pharmaceuticals is in 1180 Uccle.
What is the equity of HM Pharmaceuticals?
At the close of the 2025 financial year, the equity of HM Pharmaceuticals amounts to 38,973 €, a solvency of 67.3% of total assets.
Who manages HM Pharmaceuticals?
The register lists 1 active mandates at HM Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HM Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →